Cargando…
Intranasal Dantrolene as a Disease-Modifying Drug in Alzheimer 5XFAD Mice
BACKGROUND/OBJECTIVE: This study compares the effectiveness and safety of intranasal versus subcutaneous administration of dantrolene in 5XFAD Alzheimer’s disease (AD) mice. METHODS: 5XFAD and wild type (WT) B6SJLF1/J mice were treated with intranasal or subcutaneous dantrolene (5 mg/kg, 3×/wk), or...
Autores principales: | Shi, Yun, Zhang, Lei, Gao, Xue, Zhang, Jing, Ben Abou, Matan, Liang, Ge, Meng, Qingcheng, Hepner, Adrian, Eckenhoff, Maryellen F., Wei, Huafeng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
IOS Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7505009/ https://www.ncbi.nlm.nih.gov/pubmed/32623395 http://dx.doi.org/10.3233/JAD-200227 |
Ejemplares similares
-
Intranasal administration of dantrolene increased brain concentration and duration
por: Wang, Jintao, et al.
Publicado: (2020) -
Effects of intranasal dantrolene nanoparticles on brain concentration and behavior in PS19 tau transgenic mice
por: Vera, Robert, et al.
Publicado: (2023) -
Current clinical application of dantrolene sodium
por: Yang, Hong Seuk, et al.
Publicado: (2023) -
A Prospective Repurposing of Dantrolene as a Multitarget Agent for Alzheimer’s Disease
por: Bolognino, Isabella, et al.
Publicado: (2019) -
Malignant hyperthermia and dantrolene sodium
por: Kim, Ha Jung, et al.
Publicado: (2019)